Fosun International LTD Zymeworks Inc. Transaction History

Fosun International LTD

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 May 10, 2019	SELL	$14.02 - $16.74 $1.23 Million - $1.47 Million	-88,008 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$10.95 - $15.44 $963,687 - $1.36 Million	88,008 New	88,008 $1.03 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $813M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.